Dr. Mukund Seshadri presents his interdisciplinary research on developing and evaluating ultrasound and photoacoustic imaging for oral oncology applications, with a focus on the prognostic utility of these methods in assessing treatment responses in head and neck cancer patients.

This event illuminates the intricacies of animal welfare legislation, specifically comparing and distinguishing differences between EU, UK, and North American standards.

In this event, we focus on the Asia Pacific region, uncovering the landscape of animal welfare legislation and its implications for pharmaceutical and biotech players.

Dr. Ann McKee will describe the emergence of chronic traumatic encephalopathy (CTE) as a distinct disease over the past 20 years.

Watch as we delve into the nuances of animal welfare legislation in North America, specifically addressing the needs of clients and suppliers in the pharmaceutical and biotech sectors.

Scientist.com’s Animal Welfare Legislation Series is a 3-part webinar series to explore animal welfare legislation in North America, Asia, and Europe. In each installment, we delve into the region-specific regulatory requirements while discussing best practices and ethical guidelines for companies and organizations involved in bio-pharma sectors. Our intent is not only to shed light on the legal aspects but also to emphasize these stakeholders’ crucial role in observing and promoting ethical practices in animal welfare.

Bas Bloem, MD reviews compensatory mechanisms, including cerebral plasticity and behavioral adaptation, in persons with Parkinson’s disease.

In this webinar, Dr. Conor McCartin discusses how phage display can be used for human antibody development.

This webinar explores closed-loop cardiac rhythm control restoration in heart-transplant patients from model development to in silico regulatory evidence for safety and efficacy trials.

In this webinar, Dr. Aaron Phillips presents his research on the neural mechanisms of hemodynamic stability.

In this webinar, Victor Arrieta highlights the link between p-ERK activation and improved survival in rGBM patients using anti-PD-1 immunotherapy.

Christopher Perry, PhD discusses how his laboratory aims to discover mechanisms by which metabolic dysfunction causes muscle weakness and apply these findings to develop new therapies for muscle disorders. Homira Osman, PhD provides a particular focus on leveraging scientific findings for practice and policy and linking trainees with patient communities.